Alto Ingredients, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Alto Ingredients, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $917.93M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $965.26M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.22B | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.34B | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $1.21B | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $897.02M | Mar 14, 2023 |
| FY2016 | Dec 31, 2016 | $1.62B | Mar 15, 2017 |
| FY2016 | Dec 31, 2015 | $1.20B | Mar 15, 2017 |
| FY2016 | Dec 31, 2014 | $1.11B | Mar 15, 2017 |
| FY2015 | Dec 31, 2013 | $911.79M | Mar 16, 2016 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $395.27M | Mar 15, 2018 |
| FY2017 | Sep 30, 2017 | $445.44M | Mar 15, 2018 |
| FY2017 | Jun 30, 2017 | $405.20M | Mar 15, 2018 |
| FY2017 | Mar 31, 2017 | $386.34M | Mar 15, 2018 |
| FY2017 | Dec 31, 2016 | $441.72M | Mar 15, 2018 |
| FY2017 | Sep 30, 2016 | $417.81M | Mar 15, 2018 |
| FY2017 | Jun 30, 2016 | $422.86M | Mar 15, 2018 |
| FY2017 | Mar 31, 2016 | $342.37M | Mar 15, 2018 |
| FY2016 | Dec 31, 2015 | $376.76M | Mar 15, 2017 |
| FY2016 | Sep 30, 2015 | $380.62M | Mar 15, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.91M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $9.72M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $15.65M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | ($27.55M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $67.78M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $52.86M | Mar 14, 2023 |
| FY2019 | Dec 31, 2019 | $3.20M | Mar 30, 2020 |
| FY2019 | Sep 30, 2019 | ($14.82M) | Mar 30, 2020 |
| FY2019 | Jun 30, 2019 | $3.97M | Mar 30, 2020 |
| FY2019 | Mar 31, 2019 | ($2.29M) | Mar 30, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.34M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | ($58.98M) | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | ($28.01M) | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | ($41.60M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $46.08M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | ($15.12M) | Mar 14, 2023 |
| FY2019 | Dec 31, 2019 | ($41.09M) | Mar 30, 2020 |
| FY2019 | Sep 30, 2019 | ($27.33M) | Mar 30, 2020 |
| FY2019 | Jun 30, 2019 | ($7.65M) | Mar 30, 2020 |
| FY2019 | Mar 31, 2019 | ($12.89M) | Mar 30, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.36M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | ($51.68M) | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | ($23.85M) | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | ($61.36M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $40.07M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $9.85M | Mar 14, 2023 |
| FY2019 | Dec 31, 2019 | ($37.92M) | Mar 30, 2020 |
| FY2019 | Sep 30, 2019 | ($23.50M) | Mar 30, 2020 |
| FY2019 | Jun 30, 2019 | ($2.74M) | Mar 30, 2020 |
| FY2019 | Mar 31, 2019 | ($10.52M) | Mar 30, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.21M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $29.74M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $29.86M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $28.08M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $29.19M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $31.98M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $35.45M | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | $36.37M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $31.52M | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $30.85M | Mar 18, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.25M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | ($3.52M) | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $22.03M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $6.05M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $26.82M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $71.68M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | ($31.23M) | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | $1.57M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $36.51M | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $37.23M | Mar 18, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.60M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $11.07M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $29.53M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $37.74M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $16.38M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $6.58M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $3.28M | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | $15.15M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $20.87M | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $19.17M | Mar 18, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $388.79M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $401.44M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $454.24M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $478.32M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $484.95M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $476.82M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $612.50M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $659.98M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $720.30M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $708.24M | Mar 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $143.55M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $176.38M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $174.68M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $170.23M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $139.74M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $180.58M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $385.45M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $340.62M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $336.60M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $289.98M | Mar 15, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $245.24M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $225.06M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $279.56M | Mar 13, 2026 |
| FY2025 | Dec 31, 2022 | $308.09M | Mar 13, 2026 |
| FY2024 | Dec 31, 2021 | $345.21M | Mar 13, 2025 |
| FY2023 | Dec 31, 2020 | $296.24M | Mar 14, 2024 |
| FY2021 | Dec 31, 2019 | $227.05M | Mar 15, 2022 |
| FY2021 | Dec 31, 2018 | $319.37M | Mar 15, 2022 |
| FY2018 | Dec 31, 2017 | $356.44M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $387.89M | Mar 15, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | $5.97M | Mar 14, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($812.09M) | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | ($824.17M) | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | ($763.91M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | ($734.64M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($691.78M) | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | ($736.60M) | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | ($720.21M) | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | ($630.00M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($568.46M) | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | ($532.23M) | Mar 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.42M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $35.47M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $30.01M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $36.46M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $50.61M | Mar 14, 2024 |
| FY2021 | Dec 31, 2020 | $47.67M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $19.00M | Mar 26, 2021 |
| FY2020 | Dec 31, 2018 | $26.63M | Mar 26, 2021 |
| FY2019 | Dec 31, 2017 | $49.49M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $64.26M | Mar 18, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $84.59M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $99.68M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $90.69M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $78.08M | Mar 14, 2024 |
| FY2021 | Dec 31, 2021 | $50.40M | Mar 15, 2022 |
| FY2020 | Dec 31, 2020 | $97.87M | Mar 26, 2021 |
| FY2019 | Dec 31, 2019 | $245.49M | Mar 30, 2020 |
| FY2019 | Dec 31, 2018 | $233.51M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $244.43M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $201.86M | Mar 15, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | (1) | Mar 15, 2022 |
| FY2018 | Dec 31, 2018 | (1) | Mar 18, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Mar 18, 2019 |
| FY2016 | Dec 31, 2016 | 0 | Mar 15, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | (1) | Mar 15, 2022 |
| FY2018 | Dec 31, 2018 | (1) | Mar 18, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Mar 18, 2019 |
| FY2016 | Dec 31, 2016 | 0 | Mar 15, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 77.31M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 76.57M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 75.70M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | 75.15M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | 72.78M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | 72.49M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | 55.51M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | 45.77M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 43.98M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | 39.77M | Mar 15, 2018 |